Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar paratyphi A and S. paratyphi B in humans

Clinical and Vaccine Immunology

Volumn 19, Issue 6, 2012, Pages 825-834

  Wahid, Rezwanul ^a   Simon, Raphael ^a   Zafar, Shah J ^a   Levine, Myron M ^a   Sztein, Marcelo B ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4BETA7 INTEGRIN; BACTERIUM LIPOPOLYSACCHARIDE; CD27 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTEGRIN; L SELECTIN; OUTER MEMBRANE PROTEIN; TYPHOID VACCINE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; CLINICAL TRIAL; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; MALE; MEMORY CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA PARATYPHI; SALMONELLA PARATYPHI B; SALMONELLA TYPHI; SEROTYPE; UNITED STATES;

ADMINISTRATION, ORAL; ADULT; ANTIBODIES, BACTERIAL; CROSS PROTECTION; CROSS REACTIONS; FEMALE; HUMAN EXPERIMENTATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; MALE; MARYLAND; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALMONELLA PARATYPHI A; SALMONELLA PARATYPHI B; SALMONELLA TYPHI; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED;

EID: 84861727541     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00058-12     Document Type: Article

References (75)

1. Agematsu K, Hokibara S, Nagumo H, Komiyama A. 2000. CD27: a memory B-cell marker. Immunol. Today 21:204-206. (Pubitemid 30259022)
2. Bargatze RF, Jutila MA, Butcher EC. 1995. Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity 3:99-108.
3. Black RE, et al. 1990. Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Vaccine 8:81-84. (Pubitemid 20112889)
4. Brandtzaeg P, Johansen FE. 2005. Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206:32-63. (Pubitemid 41105162)
5. Calderon I, et al. 1986. Antibodies to porin antigens of Salmonella typhi induced during typhoid infection in humans. Infect. Immun. 52:209-212. (Pubitemid 16137703)
6. Carlin NI, Svenson SB, Lindberg AA. 1987. Role of monoclonal O-antigen antibody epitope specificity and isotype in protection against experimental mouse typhoid. Microb. Pathog. 2:171-183. (Pubitemid 17032453)
7. Crotty S, Aubert RD, Glidewell J, Ahmed R. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111-122. (Pubitemid 38490401)
8. Crotty S, et al. 2003. Long-term B cell memory in humans after smallpox vaccination. J. Immunol. 171:4969-4973. (Pubitemid 37432774)
9. Crump JA, Luby SP, Mintz ED. 2004. The global burden of typhoid fever. Bull. World Health Organ. 82:346-353. (Pubitemid 38715071)
10. Crump JA, Mintz ED. 2010. Global trends in typhoid and paratyphoid fever. Clin. Infect. Dis. 50:241-246.
11. Darveau RP, Hancock RE. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831-838. (Pubitemid 13048117)
12. El-Kamary SS, et al. 2010. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J. Infect. Dis. 202:1649-1658.
13. Fangtham M, Wilde H. 2008. Emergence of Salmonella paratyphi A as a major cause of enteric fever: need for early detection, preventive measures, and effective vaccines. J. Travel Med. 15:344-350.
14. Ferreccio C, Levine MM, Rodriguez H, Contreras R. 1989. Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J. Infect. Dis. 159:766-769. (Pubitemid 19105635)
15. Forrest BD, LaBrooy JT, Beyer L, Dearlove CE, Shearman DJ. 1991. The human humoral immune response to Salmonella typhi Ty21a. J. Infect. Dis. 163:336-345.
16. Gat O, et al. 2011. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella paratyphi a vaccines. PLoS Negl. Trop. Dis. 5:e1373. doi:10.1371/journal.pntd.0001373.
17. Germanier R, Fuer E. 1975. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J. Infect. Dis. 131:553-558.
18. Gupta SK, et al. 2008. Laboratory-based surveillance of paratyphoid fever in the United States: travel and antimicrobial resistance. Clin. Infect. Dis. 46:1656-1663.
19. Harris AM, et al. 2009. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect. Immun. 77:3850-3856.
20. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. 2000. Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165:618-622. (Pubitemid 30484724)
21. Hone DM, et al. 1988. A galE via (Vi antigen-negative) mutant of Salmonella typhi Ty2 retains virulence in humans. Infect. Immun. 56:1326-1333.
22. Isibasi A, et al. 1988. Protection against Salmonella typhi infection in mice after immunization with outer membrane proteins isolated from Salmonella typhi 9,12,d, Vi. Infect. Immun. 56:2953-2959. (Pubitemid 18259954)
23. Isibasi A, et al. 1992. Active protection of mice against Salmonella typhi by immunization with strain-specific porins. Vaccine 10:811-813.
24. Isibasi A, et al. 1994. Role of porins from Salmonella typhi in the induction of protective immunity. Ann. N. Y. Acad. Sci. 730:350-352. (Pubitemid 24292251)
25. Jaimes MC, et al. 2004. Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children. J. Virol. 78:10967-10976. (Pubitemid 39299637)
26. Jayasekera CR, et al. 2008. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J. Infect. Dis. 198:1055-1061.
27. Kantele A. 1990. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 8:321-326. (Pubitemid 20264807)
28. Kantele A, Arvilommi H, Kantele JM, Rintala L, Makela PH. 1991. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microb. Pathog. 10:117-126.
29. Kantele A, Westerholm M, Kantele JM, Makela PH, Savilahti E. 1999. Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in humans. Vaccine 17:229-236. (Pubitemid 28552782)
30. Kirkpatrick BD, et al. 2005. Comparison of the antibodies in lymphocyte supernatant and antibody-secreting cell assays for measuring intestinal mucosal immune response to a novel oral typhoid vaccine (M01ZH09). Clin. Diagn. Lab. Immunol. 12:1127-1129. (Pubitemid 41324549)
31. Kirkpatrick BD, et al. 2005. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. J. Infect. Dis. 192:360-366.
32. Klein U, Rajewsky K, Kuppers R. 1998. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679-1689. (Pubitemid 28516113)
33. Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. 1996. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14:435-438. (Pubitemid 26151877)
34. Kollaritsch H, et al. 2000. Local and systemic immune responses to combined Vibrio cholerae CVD103-HgR and Salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization. Vaccine 18:3031-3039. (Pubitemid 30303808)
35. Levine MM, et al. 1999. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine 17(Suppl. 2):S22-S27. (Pubitemid 29457532)
36. Levine MM, Ferreccio C, Black RE, Germanier R. 1987. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet i:1049-1052. (Pubitemid 17061327)
37. Levine MM, et al. 2007. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B. Clin. Infect. Dis. 45(Suppl. 1):S24-S28. (Pubitemid 47036021)
38. Levine MM, Sztein MB. 2004. Vaccine development strategies for improving immunization: the role of modern immunology. Nat. Immunol. 5:460-464. (Pubitemid 38660452)
39. Lindow JC, Fimlaid KA, Bunn JY, Kirkpatrick BD. 2011. Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi. Infect. Immun. 79:3188-3194.
40. Liu D, Verma NK, Romana LK, Reeves PR. 1991. Relationships among the rfb regions of Salmonella serovars A, B, and D. J. Bacteriol. 173:4814-4819.
41. Lundin BS, Johansson C, Svennerholm AM. 2002. Oral immunization with a Salmonella enterica serovar typhi vaccine induces specific circulating mucosa-homing CD4(+) and CD8(+) T cells in humans. Infect. Immun. 70:5622-5627.
42. Meltzer E, Sadik C, Schwartz E. 2005. Enteric fever in Israeli travelers: a nationwide study. J. Travel Med. 12:275-281. (Pubitemid 43074390)
43. Meltzer E, Schwartz E. 2010. Enteric fever: a travel medicine oriented view. Curr. Opin. Infect. Dis. 23:432-437.
44. Merrell DS, Falkow S. 2004. Frontal and stealth attack strategies in microbial pathogenesis. Nature 430:250-256. (Pubitemid 38902438)
45. Nikaido H. 1983. Proteins forming large channels from bacterial and mitochondrial outer membranes: porins and phage lambda receptor protein. Methods Enzymol. 97:85-100.
46. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656. (Pubitemid 37549772)
47. Pakkanen SH, et al. 2010. Expression of homing receptors on IgA1 and IgA2 plasmablasts in blood reflects differential distribution of IgA1 and IgA2 in various body fluids. Clin. Vaccine Immunol. 17:393-401.
48. Parry CM, Threlfall EJ. 2008. Antimicrobial resistance in typhoidal and nontyphoidal salmonellae. Curr. Opin. Infect. Dis. 21:531-538.
49. Salazar-Gonzalez RM, et al. 2004. Induction of cellular immune response and anti-Salmonella enterica serovar typhi bactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever. Immunol. Lett. 93:115-122. (Pubitemid 38670363)
50. Salerno-Goncalves R, Fernandez-Vina M, Lewinsohn DM, Sztein MB. 2004. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 173:5852-5862. (Pubitemid 39392176)
51. Salerno-Goncalves R, Pasetti MF, Sztein MB. 2002. Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J. Immunol. 169:2196-2203. (Pubitemid 34857688)
52. Salerno-Goncalves R, Sztein MB. 2006. Cell-mediated immunity and the challenges for vaccine development. Trends Microbiol. 14:536-542. (Pubitemid 44755485)
53. Salerno-Goncalves R, Wahid R, Sztein MB. 2005. Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires. Infect. Immun. 73:3521-3530. (Pubitemid 40745896)
54. Salerno-Goncalves R, et al. 2003. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. J. Immunol. 170:2734-2741. (Pubitemid 36245668)
55. Sallusto F, Lanzavecchia A, Araki K, Ahmed R. 2010. From vaccines to memory and back. Immunity 33:451-463.
56. Shyjan AM, Bertagnolli M, Kenney CJ, Briskin MJ. 1996. Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) demonstrates structural and functional similarities to the alpha 4 beta 7-integrin binding domains of murine MAdCAM-1, but extreme divergence of mucin-like sequences. J. Immunol. 156:2851-2857. (Pubitemid 126660631)
57. Simanjuntak CH, et al. 1991. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet 338:1055-1059.
58. Simon JK, et al. 2011. Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates. Clin. Immunol. 139:185-192.
59. Simon JK, et al. 2009. Antigen-specific B memory cell responses to lipo-polysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates. Vaccine 27:565-572.
60. Sundstrom P, Lundin SB, Nilsson LA, Quiding-Jarbrink M. 2008. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur.J. Immunol. 38:3327-3338.
61. Sztein MB. 2007. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica serovar Typhi strains used as live oral vaccines in humans. Clin. Infect. Dis. 45(Suppl. 1):S15-S19. (Pubitemid 47036019)
62. Sztein MB, Tanner M, Polotsky Y, Orenstein JM, Levine MM. 1995. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol. 155:3987-3993.
63. Sztein MB, et al. 1994. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170:1508-1517. (Pubitemid 24369911)
64. Tacket CO, et al. 1986. Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J. Infect. Dis. 154:342-345. (Pubitemid 16038247)
65. Tacket CO, Levine MM. 2007. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression. Clin. Infect. Dis. 45(Suppl. 1):S20-S23. (Pubitemid 47036020)
66. Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM. 2004. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. J. Infect. Dis. 190:565-570. (Pubitemid 38982097)
67. Tacket CO, et al. 1997. Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect. Immun. 65:452-456. (Pubitemid 27053208)
68. Tacket CO, et al. 2000. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect. Immun. 68:1196-1201. (Pubitemid 30108510)
69. Tagliabue A, et al. 1986. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J. Immunol. 137:1504-1510. (Pubitemid 16014798)
70. Viret JF, et al. 1999. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria. Infect. Immun. 67:3680-3685.
71. Wahid R, et al. 2011. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular poly-saccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans. Clin. Immunol. 138:187-200.
72. Wahid R, Salerno-Goncalves R, Tacket CO, Levine MM, Sztein MB. 2007. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine 25:1416-1425. (Pubitemid 46091821)
73. Wahid R, Salerno-Goncalves R, Tacket CO, Levine MM, Sztein MB. 2008. Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue-homing potential by oral attenuated CVD 909 typhoid vaccine in humans. Mucosal Immunol. 1:389-398.
74. Weinstein DL, O'Neill BL, Hone DM, Metcalf ES. 1998. Differential early interactions between Salmonella enterica serovar Typhi and two other pathogenic Salmonella serovars with intestinal epithelial cells. Infect. Immun. 66:2310-2318. (Pubitemid 28194135)
75. Wyant TL, Tanner MK, Sztein MB. 1999. Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells. Infect. Immun. 67:1338-1346. (Pubitemid 29108514)